Clinical characteristics and risk factors of severe COVID-19

What is the physiology behind comorbidities that put patients at higher risk of severe COVID-19?

With the world impacted by COVID-19 throughout 2020 and 2021, healthcare has had to adapt. In some countries, a level of normal healthcare and physiotherapy treatment has resumed. With the aid of additional protections such as vaccines, protective equipment and social distancing guidelines, many physiotherapists have resumed treating clients, inspite of COVID-19 being a present threat to both parties.

The number and the severity of COVID-19 cases, but also hospitalisation and mortality rates are still continuously tracked in many countries. Often, clinicians need to consider a patient’s comorbidities, age, and associated risk factors, as some populations are deemed at high risk for developing severe COVID-19.

This paper aims to review the risk factors for developing severe COVID-19, since this is something that needs to be considered by clinicians working with the general public.


Curious about the rest of the article?

Sign up as a member of the Anatomy & Physiotherapy Society. 
Check out the benefits of a membership and give it a try today! 
Or have a look at our monthly featured article (free) on our homepage.

Already a member? Login below

Signup for our weekly or monthly newsletter and get notified on updates on the themes you're interested in:

Please enable the javascript to submit this form

Anatomy & Physiotherapy is a joint venture
between SoPhy & Sharing Science

Summaries on Physiotherapy B.V.
Berkenweg 7
Postbus 1161
3800 BD Amersfoort
The Netherlands

Chamber of commerce: 74973738
Bank: NL72ABNA0849809959
V.A.T. number: NL860093530B01

Sharing Science
Rijksweg Zuid 99
6134 AA Sittard
The Netherlands
Chamber of Commerce: 58306862